INHALERX LIMITED

0.00%

3.5¢

Market Cap $7.470M

Technology Scientific & Technical Instruments

InhaleRx Limited is an Australia-based healthcare company. The Company is focused on... InhaleRx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. It is engaged in the development of precision medicine delivered through inhalation. The Company is focused on the development of innovative inhaled therapeutics. The Company’s novel drug device combinations target the treatment of breakthrough cancer pain (BTcP) (IRX211) and panic disorder (PD)(IRX611a), with the objective of helping to improve the quality of life of BTcP and PD sufferers. IRX211 is a THC based synthetic cannabinoid derived drug (dronabinol) delivered via a pMDI in a fixed dose designed to provide rapid onset analgesia for patients suffering with acute episodic bursts of breakthrough pain. It holds an approved innovation patent and has lodged an Australian provisional patent application for the treatment of BTcP with the Australian Patent Office.More

Latest Threads

Tag

Subject

IRX

Ann: HREC Approval to Commence Phase 1 Trial of IRX616a

01/09/25

494

01/09/25

Last post Surandy70

494

IRX

Ann: Half Yearly Report and Accounts

27/08/25

378

27/08/25

Last post The Stig

378

IRX

Ann: Fully Funded Manufacturing Commences -IRX-211 Ph2 Trial

25/08/25

1.7K

25/08/25

Last post Surandy70

1.7K

IRX

IRX 616a World 1st Fast Acting Non Addictive Anxiety Solution

21/08/25

4.3K

21/08/25

Last post Snorkel49

4.3K

IRX

Ann: Shareholder Town Hall Slides - 12pm AEST 23 Jul25

20/08/25

2.9K

20/08/25

Last post Surandy70

2.9K

IRX

Ann: Shareholder Town Hall - 12pm AEST, Wed 23 Jul25

29/07/25

756

29/07/25

Last post bavarian1975

756

IRX

Ann: Jun25 Quarterly Activities Report

22/07/25

821

22/07/25

Last post MoonBuggy

821

IRX

Ann: Jun25 Appendix 4C Cash Flow Report

22/07/25

224

22/07/25

Last post

ASX News

224

See All Discussions

Timeline

HREC Approval to Commence Phase 1 Trial of IRX616a
28 Aug 09:50	Share

Half Yearly Report and Accounts
25 Aug 09:55	Share

Shareholder Town Hall Slides - 12pm AEST 23 Jul25
23 Jul 11:54	Share

Jun25 Appendix 4C Cash Flow Report
22 Jul 11:37	Share

Jun25 Quarterly Activities Report
22 Jul 11:36	Share

Shareholder Town Hall - 12pm AEST, Wed 23 Jul25
16 Jul 12:27	Share

Issue of Director Rights in Lieu of Fees and Options
08 Jul 14:35	Share

Notification regarding unquoted securities - IRX
08 Jul 14:31	Share

Proposed issue of securities - IRX
07 Jul 17:01	Share

Fully Funded Manufacturing Commences -IRX-211 Ph2 Trial
03 Jul 09:41	Share

Receipt of R&D Tax Incentive Rebate
20 Jun 10:57	Share

HREC Approval for Redesigned IRX-211 Phase 2 Trial
03 Jun 14:59	Share

Results of 2025 AGM
29 May 19:12	Share

2025 AGM Slides
29 May 15:58	Share

Change of Director's Interest Notice - Sean Williams
15 May 15:11	Share

Notification of cessation of securities - IRX
13 May 10:38	Share

2025 AGM Access Letter
29 Apr 10:25	Share

2025 AGM Sample Proxy
29 Apr 10:24	Share

2025 AGM Notice of Meeting
29 Apr 10:23	Share

Mar25 Appendix 4C Cash Flow Report
28 Apr 12:06	Share

Mar25 Quarterly Activities Report
28 Apr 12:06	Share

IRX Completes First Drawdown Under Clendon Facility
24 Apr 11:20	Share

IRX-616a Study Order Executed to Commence Phase 1
17 Apr 09:47	Share

2024 Corporate Governance Statement
28 Mar 16:59	Share

2024 Appendix 4G
28 Mar 16:58	Share

2024 Annual Report
28 Mar 16:58	Share

Shareholder Town Hall - Webinar Slides
14 Mar 15:32	Share

Study Order Executed for Phase 2 BTcP Trial
13 Mar 14:50	Share

Results of General Meeting
06 Mar 18:06	Share

General Meeting Slides
06 Mar 15:57	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.5¢		Change 0.000(0.00%)		Mkt cap ! $7.470M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	200000	3.3¢

Sellers (Offers)

Price($)	Vol.	No.
3.8¢	114186	1

View Market Depth

No.	Vol.	Price($)
1	200000	0.033
1	100157	0.032
2	309761	0.030
1	25000	0.025
1	70000	0.014

Price($)	Vol.	No.
0.038	114186	1
0.040	386856	3
0.041	184524	1
0.050	307982	2
0.100	6942	1

Last trade - 16.21pm 04/09/2025 (20 minute delay)

IRX (ASX) Chart

Day chart unavailable

INHALERX LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

InhaleRX sets up Phase 1 trial for panic disorder inhaler

InhaleRX Ltd has executed a Study Order with iNGENū CRO Pty Ltd to oversee its Phase 1 trial for cannabidiol inhaler IRX-616a

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News